WT1 and neoplasm: Thirty-one of these tumours were positive for WT1 expression by immunohistochemistry, a marker of serous cell type in EOC, thus confirming our histopathological subclassification [57]; all clear cell and endometrioid cancers in this study were negative for WT1 expression (data not shown).